HCPCS Level II J9043: Injection, cabazitaxel, 1 mg
HCPCS Level II code J9043 describes the billed drug product for an injectable chemotherapy agent, cabazitaxel, with the descriptor Injection, cabazitaxel, 1 mg; this code represents administration/dispensing of cabazitaxel measured per 1 mg unit, typically used in oncology care and administered via intravenous infusion in hospital outpatient or infusion center settings.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J9043 policy alerts
Get alerted when payer policies referencing J9043 are released or updated.
Monitor payer policy activity